These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36992612)

  • 1. How can entrepreneurs experience inform responsible health innovation policies? A longitudinal case study in Canada and Brazil.
    Lehoux P; Silva HP; Miller F; Denis JL; Pozelli RS
    Int J Health Plann Manage; 2023 Jul; 38(4):967-985. PubMed ID: 36992612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovation Strategies and Health System Guiding Principles to Address Equity and Sustainability in Responsible Innovation in Health Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review".
    Buttigieg SC
    Int J Health Policy Manag; 2019 Sep; 8(9):570-572. PubMed ID: 31657182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review.
    Lehoux P; Roncarolo F; Silva HP; Boivin A; Denis JL; Hébert R
    Int J Health Policy Manag; 2019 Feb; 8(2):63-75. PubMed ID: 30980619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing responsible innovation in health: a policy-oriented framework.
    Pacifico Silva H; Lehoux P; Miller FA; Denis JL
    Health Res Policy Syst; 2018 Sep; 16(1):90. PubMed ID: 30200985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fostering Responsible Innovation in Health: An Evidence-Informed Assessment Tool for Innovation Stakeholders.
    Silva HP; Lefebvre AA; Oliveira RR; Lehoux P
    Int J Health Policy Manag; 2021 Mar; 10(4):181-191. PubMed ID: 32610749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsible innovation in health and health system sustainability: Insights from health innovators' views and practices.
    Lehoux P; Silva HP; Rocha de Oliveira R; Sabio RP; Malas K
    Health Serv Manage Res; 2022 Nov; 35(4):196-205. PubMed ID: 34866461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Innovation and Entrepreneurship Policy of Scientific and Technological Entrepreneur Talent Using Regional Competitive Advantage Theory.
    Yu X; Du B
    Front Psychol; 2021; 12():726334. PubMed ID: 34970179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nurturing Societal Values in and Through Health Innovations Comment on "What Health System Challenges Should Responsible Innovation in Health Address?".
    Abrishami P; Repping S
    Int J Health Policy Manag; 2019 Oct; 8(10):613-615. PubMed ID: 31657189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovation, Demand, and Responsibility: Some Fundamental Questions About Health Systems Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review".
    van Lente H
    Int J Health Policy Manag; 2019 Sep; 8(9):567-569. PubMed ID: 31657181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.
    Lehoux P; Miller FA; Daudelin G; Denis JL
    Int J Health Policy Manag; 2017 Sep; 6(9):509-518. PubMed ID: 28949463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who is Responsible for Responsible Innovation? Lessons From an Investigation into Responsible Innovation in Health Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review".
    Stahl BC
    Int J Health Policy Manag; 2019 Jul; 8(7):447-449. PubMed ID: 31441281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resilience in Healthcare (RiH): a longitudinal research programme protocol.
    Aase K; Guise V; Billett S; Sollid SJM; Njå O; Røise O; Manser T; Anderson JE; Wiig S
    BMJ Open; 2020 Oct; 10(10):e038779. PubMed ID: 33109657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment-responsible innovation in health approach in the "new normal".
    Mukherjee K; Walley T
    Int J Technol Assess Health Care; 2022 May; 38(1):e47. PubMed ID: 35549786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada.
    Rosenberg-Yunger ZR; Daar AS; Singer PA; Martin DK
    Health Policy; 2008 Sep; 87(3):359-68. PubMed ID: 18358556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policymaker and stakeholder perspectives on access to assistive technologies in Canada: challenges and proposed solutions for enhancing equitable access.
    Wang RH; Zdaniuk N; Durocher E; Wilson MG
    Disabil Rehabil Assist Technol; 2022 Jan; 17(1):61-73. PubMed ID: 32489125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equity consideration in palliative care policies, programs, and evaluation: an analysis of selected federal and South Australian documents.
    Javanparast S; Anaf J; Tieman J
    BMC Palliat Care; 2022 Jun; 21(1):109. PubMed ID: 35710402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EQUIP Healthcare: An overview of a multi-component intervention to enhance equity-oriented care in primary health care settings.
    Browne AJ; Varcoe C; Ford-Gilboe M; Wathen CN;
    Int J Equity Health; 2015 Dec; 14():152. PubMed ID: 26694168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can Health in All Policies approaches support the transition to the well-being economy?
    Valentine N; Williams C; Vega J; Solar O; Told M
    Health Promot J Austr; 2023 Jul; 34(3):629-633. PubMed ID: 37379857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and innovation: economic dynamics and Welfare State in Brazil.
    Gadelha CA; Braga PS
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00150115. PubMed ID: 27828678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
    Coghlan R; Stephens P; Mwale B; Siyanga M
    Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.